L’Oreal SA (EPA: OR)‘s stock had its “reduce” rating restated by analysts at AlphaValue in a research report issued to clients and investors on Thursday. They currently have a $134.21 (€102) price target on the stock.

OR has been the subject of a number of other recent research reports. Analysts at RBC Capital reiterated an “outperform” rating on shares of L’Oreal SA in a research note to investors on Wednesday, October 10th. They now have a $137.18 price target on the stock. Analysts at Sanford C. Bernstein reiterated an “underperform” rating on shares of L’Oreal SA in a research note to investors on Tuesday, October 2nd. They now have a $117.95 price target on the stock.

L’Oreal SA traded down 0.79% on Thursday, hitting €100.80. L’Oreal SA has a 1-year low of €74.15 and a 1-year high of €102.50. The company has a market cap of €60.485 billion and a price-to-earnings ratio of 23.55.

L’Oreal SA is a France-based cosmetic group. It is structured into three branches: Cosmetics, The Body Shop and Dermatology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.